A randomized, single-blind, single-dose study evaluating the pharmacokinetic equivalence of proposed biosimilar ABP 980 and trastuzumab in healthy male subjects - Hanes, V; Chow, V; Zhang, N (Cancer Chemother Pharmacol, 2017)
et al.